» Articles » PMID: 16936211

Enhanced Proatherogenic Responses in Macrophages and Vascular Smooth Muscle Cells Derived from Diabetic Db/db Mice

Overview
Journal Diabetes
Specialty Endocrinology
Date 2006 Aug 29
PMID 16936211
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is associated with enhanced inflammatory responses and cardiovascular complications such as atherosclerosis. However, it is unclear whether similar responses are present in cells derived from experimental animal models of diabetes. We examined our hypothesis that macrophages and short-term cultured vascular smooth muscle cells (VSMCs) derived from obese, insulin-resistant, and diabetic db/db mice would exhibit increased proatherogenic responses relative to those from control db/+ mice. We observed that macrophages from db/db mice exhibit significantly increased expression of key inflammatory cytokines and chemokines as well as arachidonic acid-metabolizing enzymes cyclooxygenase-2 and 12/15-lipoxygenase that generate inflammatory lipids. Furthermore, VSMCs derived from db/db mice also showed similar enhanced expression of inflammatory genes. Expression of inflammatory genes was also significantly increased in aortas derived from db/db mice. Both macrophages and VSMCs from db/db mice demonstrated significantly increased oxidant stress, activation of key signaling kinases, and transcription factors cAMP response element-binding protein and nuclear factor-kappaB, involved in the regulation of atherogenic and inflammatory genes. Interestingly, VSMCs from db/db mice displayed enhanced migration as well as adhesion to WEHI mouse monocytes relative to db/+. Thus, the diabetic milieu and a potential hyperglycemic memory can induce aberrant behavior of vascular cells. These new results demonstrate that monocyte/macrophages and VSMCs derived from db/db mice display a "preactivated" and proinflammatory phenotype associated with the pathogenesis of diabetic vascular dysfunction and atherosclerosis.

Citing Articles

Update: the role of epigenetics in the metabolic memory of diabetic complications.

Chen Z, Malek V, Natarajan R Am J Physiol Renal Physiol. 2024; 327(3):F327-F339.

PMID: 38961840 PMC: 11460341. DOI: 10.1152/ajprenal.00115.2024.


Metabolic memory: mechanisms and diseases.

Dong H, Sun Y, Nie L, Cui A, Zhao P, Leung W Signal Transduct Target Ther. 2024; 9(1):38.

PMID: 38413567 PMC: 10899265. DOI: 10.1038/s41392-024-01755-x.


Regulatory Mechanism of lncRNAs in M1/M2 Macrophages Polarization in the Diseases of Different Etiology.

Jiang P, Li X Front Immunol. 2022; 13:835932.

PMID: 35145526 PMC: 8822266. DOI: 10.3389/fimmu.2022.835932.


Role of myeloid cell leptin signaling in the regulation of glucose metabolism.

Pereira S, Cline D, Chan M, Chai K, Yoon J, ODwyer S Sci Rep. 2021; 11(1):18394.

PMID: 34526546 PMC: 8443652. DOI: 10.1038/s41598-021-97549-0.


Basics of Epigenetics and Role of Epigenetics in Diabetic Complications.

Yamunadevi A, Pratibha R, Rajmohan M, Mahendraperumal S, Ganapathy N J Pharm Bioallied Sci. 2021; 13(Suppl 1):S336-S343.

PMID: 34447105 PMC: 8375876. DOI: 10.4103/jpbs.JPBS_771_20.